NEWS
APRIL 30TH 2020
Luspatercept receives positive CHMP opinion by EMA
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/reblozyl
APRIL 3RD 2020
FDA approves luspatercept for anemia in adults with MDS
Luspatercept receives positive CHMP opinion by EMA
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/reblozyl
FDA approves luspatercept for anemia in adults with MDS